SQZ Biotechnologies (SQZ)
NYSE: SQZ
· Real-Time Price · USD
0.43
0.16 (59.26%)
At close: Jul 03, 2023, 7:00 PM
SQZ Biotechnologies Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | n/a | -16.77M | -17.69M | -13.55M | -22.64M | -22.24M | -21.04M | -11.82M | -22.45M | -19.07M | -15.4M |
Depreciation & Amortization | n/a | 2.24M | 3.05M | 3.39M | 2.85M | 2.69M | 2.75M | 2.71M | 2.78M | 2.73M | 2.8M |
Stock-Based Compensation | 3.88M | 1.15M | 695K | 1.77M | 2.38M | 2.31M | 1.95M | 2.31M | 2.78M | 1.83M | 1.58M |
Other Working Capital | n/a | -866K | -9.81M | -14.57M | -6.12M | -3.69M | -2.87M | -12.8M | -4.29M | -3.78M | -5.45M |
Other Non-Cash Items | -3.88M | -106K | n/a | -10K | 1K | 1K | 41K | -32.94M | 1K | 6K | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 32.94M | n/a | n/a | n/a |
Change in Working Capital | n/a | -1.79M | -9.83M | -12.37M | -4.46M | -3.24M | -4.14M | -14.22M | -4M | -5.14M | -9.57M |
Operating Cash Flow | 3.88M | -15.27M | -23.77M | -20.76M | -21.88M | -20.48M | -20.43M | -21.02M | -20.89M | -19.64M | -20.58M |
Capital Expenditures | n/a | -47K | -65K | -101K | -113K | -80K | -228K | n/a | -92K | -274K | -247K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | 155K | n/a | n/a | n/a | n/a | 34K | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | 108K | -65K | -101K | -113K | -80K | -194K | n/a | -92K | -274K | -247K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | 29K | n/a | n/a | n/a | 103K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 331K | 670K | 3.2M | 29K | 279K | 171K | 53K | 55.4M |
Financial Cash Flow | n/a | n/a | n/a | 331K | 670K | 3.2M | 29K | 279K | 171K | 53K | 55.4M |
Net Cash Flow | 3.88M | -15.16M | -23.84M | -20.53M | -21.32M | -17.35M | -20.6M | -20.74M | -20.81M | -19.86M | 34.57M |
Free Cash Flow | 3.88M | -15.32M | -23.84M | -20.86M | -21.99M | -20.56M | -20.66M | -21.02M | -20.98M | -19.91M | -20.83M |